| KOTAK INDIA GROWTH FUND SERIES 7
Multicap Fund - A 36 months close ended equity scheme investing across large cap, midcap and small cap stocks.
| KOTAK INDIA GROWTH FUND SERIES 7
Multicap Fund - A 36 months close ended equity scheme investing across large cap, midcap and small cap stocks.

      

      
Investment Objective

The investment objective of the scheme is to generate capital appreciation from a diversified portfolio of equity & equity related instruments across market capitalisation and sectors. It also endeavors to manage risks through equity derivatives.
There is no assurance or guarantee that the investment objective of the scheme will be achieved.

The investment objective of the scheme is to generate capital appreciation from a diversified portfolio of equity & equity related instruments across market capitalisation and sectors. It also endeavors to manage risks through equity derivatives.
There is no assurance or guarantee that the investment objective of the scheme will be achieved.

Issuer/Instrument Industry/
Rating
% to Net
Assets

Equity & Equity related
Banks 31.97
HDFC Bank Ltd. 9.64
ICICI Bank Ltd. 9.30
Axis Bank Ltd. 3.67
State Bank Of India 3.61
Kotak Mahindra Bank Ltd. 3.55
AU Small Finance Bank Ltd. 2.20
Software 14.78
Infosys Ltd. 8.49
Tata Consultancy Services Ltd. 5.06
Tech Mahindra Ltd. 1.23
Petroleum Products 9.74
Reliance Industries Ltd. 8.28
Bharat Petroleum Corporation Ltd. 1.07
Reliance Industries Ltd - Partly Paid Shares 0.39
Finance 6.67
Aavas Financiers Ltd. 1.80
SBI Cards & Payment Services Pvt. Ltd. 1.37
Bajaj Finance Ltd. 1.36
HDFC Life Insurance Company Ltd. 1.13
ICICI Lombard General Insurance Company Ltd 1.01
Industrial Products 6.33
Supreme Industries Limited 3.44
SRF Ltd. 2.89
Consumer Non Durables 6.06
Hindustan Unilever Ltd. 3.37
Britannia Industries Ltd. 1.61
Godrej Consumer Products Ltd. 1.08
Cement 5.76
Ultratech Cement Ltd. 3.09
Shree Cement Ltd. 2.67
Construction Project 4.15
Larsen And Toubro Ltd. 4.15
Auto 3.99
Maruti Suzuki India Limited 2.61
Mahindra & Mahindra Ltd. 1.38
Pharmaceuticals 2.66
Torrent Pharmaceuticals Ltd. 1.67
Dr Reddys Laboratories Ltd. 0.99
Telecom - Services 2.41
Bharti Airtel Ltd 2.41
Fertilisers 2.09
Coromandel International Ltd. 2.09
Gas 1.97
Gujarat State Petronet Ltd. 1.97
Equity & Equity Related - Total 98.58
Option
CNX NIFTY - 11400.000 - Put Option - June 2021 0.25
CNX NIFTY - 11200.000 - Put Option - June 2021 0.06
Options - Total 0.31
Triparty Repo 0.72
Net Current Assets/(Liabilities) 0.39
Grand Total 100.00

Term Deposit as provided above is towards margin for derivatives transactions
Equity Derivative Exposuer is 0.31%



NAV
Dividend Option Rs12.803
Direct Dividend Option Rs 13.152
Growth Option Rs12.803
Direct Growth Option Rs13.152

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Dividend Payout & Growth (applicable for all plans)


Fund Manager Ms. Shibani Kurian*
BenchmarkNifty 50 TRI
Allotment dateAugust 31, 2018
AAUMRs42.17 crs
AUMRs41.39 crs
Folio count561

Dividend Frequency

Trustee's Discretion


Ratios
Portfolio Turnover16.48%

Minimum Investment Amount

The scheme is a close ended scheme. The units of the scheme can be traded on the stock exchange.


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load: Nil. (applicable for all plans)


Total Expense Ratio**

Regular: 1.26%; Direct: 0.18%


Data as on February 28, 2021


This product is suitable for investors who are seeking*:
  • Long term capital growth.
  • Investment in equity and equity related securities without any market capitalisation and sector bias.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.


**Total Expense Ratio includes applicable B30 fee and GST
* For Fund Manager experience, please refer 'Our Fund Managers'
For scheme performance, please refer 'Scheme Performances'